首页 › 基金 › GW&K Investment Management, LLC › LGND
GW&K Investment Management, LLC 对 LGND 的持仓历史
LIGAND PHARMACEUTICALS INC · 医疗保健
GW&K Investment Management, LLC 在 Q3 2026 的 13F 申报中披露持有 LGND(LIGAND PHARMACEUTICALS INC)241,758 股,市值约 US$75.5M,约占其申报组合的 0.64%,在其申报持仓中市值排名第 37 位。 GW&K Investment Management, LLC 最近 13 个申报季度中有 13 个季度披露了 LGND 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
GW&K Investment Management, LLC 对 LGND 的持仓演变
GW&K Investment Management, LLC 于 Q3 2023 首次披露 LGND 持仓:37,430 股(约 US$2.2M)。 该持仓在 Q2 2026 达到峰值 246,883 股,市值约 US$78.0M。 在 13 次申报中,GW&K Investment Management, LLC 4 次增持、8 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 241,758 股、市值约 US$75.5M,环比减持 -5,125 股。。 持仓曾出现大幅变动:Q4 2023 增持约 48% (随后一个季度股价上涨 2%)、Q4 2025 增持约 265% (随后一个季度股价上涨 6%)、Q2 2026 增持约 65% (随后一个季度股价下跌 1%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 37.43K | $2.24M | 新进 |
| Q4 2023 | 55.34K | $3.95M | 增持 |
| Q1 2024 | 39.77K | $2.91M | 减持 |
| Q2 2024 | 39.02K | $3.29M | 减持 |
| Q3 2024 | 37.76K | $3.78M | 减持 |
| Q4 2024 | 35.18K | $3.77M | 减持 |
| Q1 2025 | 34.86K | $3.67M | 减持 |
| Q2 2025 | 33.43K | $3.80M | 减持 |
| Q3 2025 | 32.13K | $5.69M | 减持 |
| Q4 2025 | 117.43K | $22.20M | 增持 |
| Q1 2026 | 149.50K | $29.85M | 增持 |
| Q2 2026 | 246.88K | $78.04M | 增持 |
| Q3 2026 | 241.76K | $75.52M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LGND 与 13F 数据
LGND(LIGAND PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 51 只申报持有 LGND,申报仓位最大的包括:CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LGND 的基金
- CONGRESS ASSET MANAGEMENT CO 658.56K 股 · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K 股 · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K 股 · $139.36M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K 股 · $85.36M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M 股 · $84.80M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K 股 · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K 股 · $57.99M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K 股 · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K 股 · $52.48M · Q2 2026
- Granahan Investment Management, LLC 147.23K 股 · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 98.75K 股 · $30.88M · Q3 2026
更多关于 GW&K Investment Management, LLC
常见问题
How long has GW&K Investment Management, LLC held LGND?
GW&K Investment Management, LLC has disclosed LGND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GW&K Investment Management, LLC's current position in LGND?
As of Q3 2026, GW&K Investment Management, LLC holds 241.76K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $75.52M, representing 0.64% of its reported portfolio and ranking #37.
Has GW&K Investment Management, LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), GW&K Investment Management, LLC reduced its position in LGND. The position peaked in Q2 2026 at 246.88K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.